Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatitis C Viral”

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT02634008
What this trial is testing

Treatment of Recently Acquired Hepatitis C With the 3D Regimen or G/P

Who this might be right for
Hepatitis C, Acute
Kirby Institute 83
Not applicableUnknownNCT01271140
What this trial is testing

High Dose Insulin Therapy to Improve Liver Function

Who this might be right for
Hepatitis C Virus
McGill University Health Centre/Research Institute of the McGill University Health Centre 5
Post-approval studies (Phase 4)Study completedNCT01045278
What this trial is testing

Hepatitis C in a Cohort of Patients With Maintenance Therapy for Opiate Dependence - Prevalence, Severity and Outcome of Antiviral Therapy

Who this might be right for
Hepatitis C
Region Skane 277
Not applicableStudy completedNCT02472925
What this trial is testing

Way to Cure HCV Adherence

Who this might be right for
Hepatitis C
University of Pennsylvania 60
Large-scale testing (Phase 3)Study completedNCT00703118
What this trial is testing

A Safety and Effectiveness Study of Telaprevir in Chronic, Genotype 1, Hepatitis C Patients That Failed Previous Standard Treatment

Who this might be right for
Hepatitis C, Chronic
Tibotec BVBA 663
Testing effectiveness (Phase 2)Study completedNCT00991289
What this trial is testing

Nitazoxanide Plus Ribavirin and Peginterferon for Therapy of Treatment Naive HCV Genotype 1 and HIV Coinfected Subjects

Who this might be right for
HIV InfectionHepatitis C Infection
National Institute of Allergy and Infectious Diseases (NIAID) 68
Not applicableStudy completedNCT03567174
What this trial is testing

Building on Needle Exchange to Optimize Prevention & Treatment

Who this might be right for
Intravenous Drug UsageHIV/AIDS
Johns Hopkins University 720
Testing effectiveness (Phase 2)Study completedNCT00925990
What this trial is testing

CTS-1027 in Interferon-Naive Hepatitis C Patients

Who this might be right for
Hepatitis C
Conatus Pharmaceuticals Inc. 70
Early research (Phase 1)Study completedNCT00359463
What this trial is testing

Study Of Eltrombopag in Healthy Subjects and Volunteers With Mild, Moderate or Severe Hepatic Impairment

Who this might be right for
Purpura, Thrombocytopaenic, Idiopathic
GlaxoSmithKline 33
Not applicableStudy completedNCT02452814
What this trial is testing

Long Term Extension Study is Designed to Monitor Long-Term Efficacy and Safety of Miravirsen Sodium in Combination With Telaprevir and Ribavirin in Subjects With Chronic Hepatitis C Virus Genotype 1 Infection

Who this might be right for
HCV
Hoffmann-La Roche 8
Not applicableUnknownNCT01178749
What this trial is testing

Exploration of Chronic Hepatitis C Infection Receiving 24-week Interferon-α With Ribavirin Treatments

Who this might be right for
Chronic Hepatitis C
National Taiwan University Hospital 390
Not applicableUnknownNCT05102838
What this trial is testing

Prospective Cohort Study on Prognosis of Patients With Hepatitis B/C

Who this might be right for
Hepatitis BHepatitis C
Sun Yat-sen University 60,000
Large-scale testing (Phase 3)Study completedNCT00200343
What this trial is testing

Efficacy and Safety Study of Ursodeoxycholic Acid to Treat Chronic Hepatitis C

Who this might be right for
Chronic Hepatitis C
Tanabe Pharma Corporation 596
Post-approval studies (Phase 4)Study completedNCT03200184
What this trial is testing

Sofosbuvir and Daclatasvir in Treating Hepatitis C, A Study on 1000 Patients

Who this might be right for
Hepatitis C
Tehran University of Medical Sciences 1,448
Post-approval studies (Phase 4)Study completedNCT03365635
What this trial is testing

Administration of Zepatier (Grazoprevir Plus Elbasvir) in Chronic Hemodialysis (HD) Patients With Hepatitis C

Who this might be right for
Hepatitis CHemodialysisNosocomial Infection
University of Pennsylvania 6
Post-approval studies (Phase 4)Study completedNCT02498015
What this trial is testing

A Phase IV Trial of Paritaprevir/Ritonavir, Ombitasvir, Dasabuvir for Chronic Hepatitis C Genotype 1 Virus Infection

Who this might be right for
Hepatitis C, Chronic
Kirby Institute 87
Post-approval studies (Phase 4)Study completedNCT00358696
What this trial is testing

Antiretroviral Switch From Didanosine to Tenofovir in HIV/HCV Co-infected Patients

Who this might be right for
HIVHIV Infections
University of British Columbia 30
Large-scale testing (Phase 3)Study completedNCT01263860
What this trial is testing

Trial of 24-Week Versus 48-Week Courses of Peginterferon Plus Ribavirin for HCV Genotype-6 Patients

Who this might be right for
Chronic Hepatitis C
Third Affiliated Hospital, Sun Yat-Sen University 242
Post-approval studies (Phase 4)Study completedNCT02214420
What this trial is testing

SMV + SOF With/Without RBV for IFN-II Patients With CHC

Who this might be right for
Hepatitis C
SC Liver Research Consortium, LLC 24
Not applicableStudy completedNCT02581189
What this trial is testing

Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C in Canada

Who this might be right for
Chronic Hepatitis C
AbbVie 565
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation